JACOBSON; Sven Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for JACOBSON; Sven Martin.The latest application filed is for "methods of treating injuries or conditions related to cns edema".

Company Profile

4.12.18

JACOBSON; Sven Martin - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Injuries Or Conditions Related To Cns Edema App 20220125750 - JACOBSON; Sven Martin	2022-04-28
Formulations And Methods For Lyophilization And Lyophilates Provided Thereby App 20210244669 - Jacobson; Sven Martin	2021-08-12
Methods Of Intravenous Administration Of Glyburide App 20210154135 - JACOBSON; Sven Martin	2021-05-27
Composition Containing Glibenclamide App 20210113500 - JACOBSON; Sven Martin ; et al.	2021-04-22
Formulations and methods for lyophilization and lyophilates provided thereby Grant 10,869,835 - Jacobson December 22, 2	2020-12-22
Methods of intravenous administration of glyburide Grant 10,786,445 - Jacobson September 29, 2	2020-09-29
Composition containing glibenclamide Grant 10,758,503 - Jacobson , et al. Sep	2020-09-01
Formulations And Methods For Lyophilization And Lyophilates Provided Thereby App 20200093747 - Jacobson; Sven Martin	2020-03-26
Composition Containing Glibenclamide App 20200093767 - JACOBSON; Sven Martin ; et al.	2020-03-26
Methods Of Intravenous Administration Of Glyburide App 20190328653 - Jacobson; Sven Martin	2019-10-31
Composition containing glibenclamide Grant 10,441,556 - Jacobson , et al. Oc	2019-10-15
Formulations and methods for lyophilization and lyophilates provided thereby Grant 10,426,729 - Jacobson October 1, 2	2019-10-01
Methods of intravenous administration of glyburide Grant 10,391,053 - Jacobson A	2019-08-27
Formulations And Methods For Lyophilization And Lyophilates Provided Thereby App 20190099372 - Jacobson; Sven Martin	2019-04-04
Methods Of Treating Injuries Or Conditions Related To Cns Edema App 20180280325 - JACOBSON; Sven Martin	2018-10-04
Treatment of Alzheimer's Disease using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulated by SUR1 Receptors App 20180271811 - JACOBSON; Sven Martin ; et al.	2018-09-27
Methods of intravenous administration of glyburide Grant 10,052,280 - Jacobson August 21, 2	2018-08-21
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA.sup.++ activated ATP-sensitive cation channels regulated by SUR1 channels Grant 10,004,703 - Jacobson , et al. June 26, 2	2018-06-26
Methods Of Intravenous Administration Of Glyburide App 20170348227 - Jacobson; Sven Martin	2017-12-07
Methods of Intravenous Administration of Glyburide App 20170333340 - Jacobson; Sven Martin	2017-11-23
Methods of intravenous administration of glyburide Grant 9,561,176 - Jacobson February 7, 2	2017-02-07
Methods of intravenous administration of glyburide Grant 9,254,259 - Jacobson February 9, 2	2016-02-09
Methods Of Intravenous Administration Of Glyburide App 20160030370 - Jacobson; Sven Martin	2016-02-04
Methods Of Intravenous Administration Of Glyburide App 20150157560 - Jacobson; Sven Martin	2015-06-11
Methods of intravenous administration of glyburide and other drugs Grant 8,946,293 - Jacobson February 3, 2	2015-02-03
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels App 20140080811 - Jacobson; Sven Martin ; et al.	2014-03-20
Methods Of Intravenous Administration Of Glyburide And Other Drugs App 20130203853 - Jacobson; Sven Martin	2013-08-08
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors App 20100056444 - Jacobson; Sven Martin ; et al.	2010-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.